Pure Global
NCT05999097

To Study the Effect of SC-FOS Prebiotics in Women With Polycystic Ovary Syndrome

To Study the Clinical Effect of SC-FOS Prebiotics in Enteral Diet vs. Standard Enteral Diet on Clinical Characteristics of Patients With Polycystic Ovary Syndrome According to the Rotterdam Classification in Chihuahua, Chihuahua. A Randomized Single-Blind Clinical Trial
Universidad Autonoma de Chihuahua·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Polycystic Ovary Syndrome
Drug/Device/Intervention
Short Chain Fructooligosaccharides
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Universidad Autonoma de Chihuahua
Location
Chihuahua, Mexico
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
Sep 30, 2023
Enrollment
40 participants
Primary outcome

Score of Bristol Scale,Score Short Form Health Survey (SF-36)

Summary

The purpose of this study is to determine if there is a difference in the clinical
 characteristics of patients with polycystic ovary syndrome after the administration of SC-FOS
 in the enteral diet compared to patients with a standard diet.

ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionNeoplasm of uncertain or unknown behaviour: Ovary
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05999097
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05999097 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidad Autonoma de Chihuahua and is currently Recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.